SCHEMBL4807375

SCHEMBL4807375

CSc1ccc(/C(Cc2ccccc2)=N/O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 3/20 0.43
HPGD P15428 1/20 0.43
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
TAS2R14 Q9NYV8 1/20 0.41
CTSL P07711 1/20 0.41
XDH P47989 3/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4807381 1.00 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL6169609 0.93 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL6169610 0.93 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL257218 0.82 CTSL (0.55) KDM4ESMN1; SMN2TSHRALOX12CTSL
SCHEMBL4586154 0.82 CTSL (0.55) KDM4ESMN1; SMN2TSHRALOX12CTSL
SCHEMBL4586157 0.82 CTSL (0.55) KDM4ESMN1; SMN2TSHRALOX12CTSL
SCHEMBL4028381 0.81 SMN1; SMN2 (0.79) KDM4ESMN1; SMN2ALDH1A1MAPTXDH
SCHEMBL4028385 0.81 SMN1; SMN2 (0.79) KDM4ESMN1; SMN2ALDH1A1MAPTXDH
SCHEMBL13853886 0.81 KDM4E (0.54) KDM4ESMN1; SMN2KMT2ATSHRALOX12
SCHEMBL8407033 0.79 MGLL (0.58) KDM4ESMN1; SMN2LMNATSHRALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329401-B2 Cyclooxygenase-2 selective agents useful as imaging probes and related methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-02-12 US disclosed
US-7329401-B2 Cyclooxygenase-2 selective agents useful as imaging probes and related methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-02-12 US disclosed
US-20070286801-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-12-13 US disclosed
US-20070286801-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-12-13 US disclosed
WO-2003089013-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-10-30 WO disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070286801-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS PTGS2, PTGES2, PTGER2 KDM4E 4237/4885SMN1; SMN2 3034/4885ALDH1A1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.